N02 - Analgesics
N02A - Opioids
N02AB - Phenylpiperidine derivatives
N02AB03 - fentanyl
N02AC - Diphenylpropylamine derivatives
N02AC54 - dextropropoxyphene, combinations excluding psycholept
N02AX - Other opioids
N02AX02 - etenzamide, combinations with psycholeptics
N02B - Other analgesics and antipyretics
N02BG - Other analgesics and antipyretics
N02BG07 - flupirtine
N02BG08 - entacapone
N02C - Antimigraine preparations
N02CD - Calcitonin gene-related peptide (CGRP) antagonists
N02CD02 - galcanezumab
N02CX - Other antimigraine preparations
N02CX04 - sumatriptan
N05 - Psycholeptics
N05A - Antipsychotics
N05AD - Butyrophenone derivatives
N05AD01 - haloperidol
N05AE - Indole derivatives
N05AE03 - sertindole
N05AE05 - lurasidone
N05AH - Diazepines, oxazepines, thiazepines and oxepines
N05AH01 - loxapine
N05AH02 - clozapine
N05AH03 - olanzapine
N05AH04 - quetiapine
N05AH05 - asenapine
N05AL - Benzamides
N05AL06 - veralipride
N05AX - Other antipsychotics
N05AX08 - risperidone
N05AX12 - aripiprazole
N05AX13 - paliperidone
N05AX14 - iloperidone
N05AX15 - cariprazine
N05AX16 - brexpiprazole
N05C - Hypnotics and sedatives
N05CD - Benzodiazepine derivatives
N05CD08 - midazolam
N05CF - Cyclopyrrolones
N05CF03 - zaleplon
N05CF04 - eszopiclone
N05CH - Melatonin receptor agonists
N05CH01 - melatonin
N05CH03 - tasimelteon
N05CM - Other hypnotics and sedatives
N05CM18 - dexmedetomidine
N06 - Psychoanaleptics
N06A - Antidepressants
N06AB - Bicyclic derivatives
N06AB03 - fluoxetine
N06AB04 - citalopram
N06AB05 - paroxetine
N06AB06 - sertraline
N06AB08 - fluvoxamine
N06AB10 - escitalopram
N06AX - Other antidepressants
N06AX11 - mirtazapine
N06AX12 - bupropion
N06AX16 - venlafaxine
N06AX17 - milnacipran
N06AX18 - reboxetine
N06AX21 - duloxetine
N06AX22 - agomelatine
N06AX26 - vortioxetine
N06AX27 - esketamine
N06B - Psychostimulants, agents used for ADHD and nootropics
N06BA - Centrally acting sympathomimetics
N06BA04 - methylphenidate
N06BA07 - modafinil
N06BA09 - atomoxetine
N06BA14 - solriamfetol
N06BC - Xanthine derivatives
N06BC01 - caffeine
N06BC02 - propentofylline
N06BX - Other psychostimulants
N06BX13 - idebenone
N06D - Anti-dementia drugs
N06DA - Anticholinesterases
N06DA03 - rivastigmine
N06DA04 - galantamine
N06DA52 - donepezil and memantine
N06DX - Other anti-dementia drugs
N06DX01 - memantine
L01 - Antineoplastic agents
L01A - Alkylating agents
L01AA - Nitrogen mustard analogues
L01AA03 - acetarsol
L01AA05 - clioquinol
L01AB - Alkyl sulphonates
L01AB01 - busulfan
L01AB02 - treosulfan
L01AC - Ethylene imines
L01AC01 - thiotepa
L01AD - Nitrosoureas
L01AD01 - carmustine
L01AX - Other alkylating agents
L01AX03 - temozolomide
L01AX04 - dacarbazine
L01B - Antimetabolites
L01BA - Folic acid analogues
L01BA01 - methotrexate
L01BA04 - anagrelide
L01BA05 - pralatrexate
L01BB - Purine analogues
L01BB02 - mercaptopurine
L01BB04 - cladribine
L01BB06 - clofarabine
L01BB07 - nelarabine
L01BC - Pyrimidine analogues
L01BC01 - cytarabine
L01BC05 - gemcitabine
L01BC06 - capecitabine
L01BC07 - azacitidine
L01BC08 - decitabine
L01BC53 - tegafur, combinations
L01BC59 - trifluridine, combinations
L01C - Plant alkaloids and other natural products
L01CA - Vinca alkaloids and analogues
L01CA05 - vinflunine
L01CA06 - vintafolide
L01CB - Podophyllotoxin derivatives
L01CB01 - etoposide
L01CD - Taxanes
L01CD01 - paclitaxel
L01CD02 - docetaxel
L01CD04 - cabazitaxel
L01CX - Other plant alkaloids and natural products
L01CX01 - trabectedin
L01D - Cytotoxic antibiotics
L01DB - Anthracyclines
L01DB01 - doxorubicin
L01DB11 - pixantrone
L01X - Other antineoplastic agents
L01XC - Monoclonal antibodies
L01XC02 - rituximab
L01XC03 - trastuzumab
L01XC04 - alemtuzumab
L01XC05 - gemtuzumab
L01XC06 - cetuximab
L01XC07 - bevacizumab
L01XC08 - panitumumab
L01XC09 - catumaxomab
L01XC10 - ofatumumab
L01XC11 - ipilimumab
L01XC12 - brentuximab vedotin
L01XC13 - pertuzumab
L01XC14 - trastuzumab emtansine
L01XC15 - trametinib
L01XC16 - dinutuximab
L01XC17 - fluciclovine (18F)
L01XC18 - pembrolizumab
L01XC19 - blinatumomab
L01XC21 - ramucirumab
L01XC22 - moxidectin
L01XC23 - elotuzumab
L01XC24 - cariprazine
L01XC25 - mogamulizumab
L01XC26 - inotuzumab ozogamicin
L01XC27 - olaratumab
L01XC31 - avelumab
L01XC32 - atezolizumab
L01XD - Sensitizers used in photodynamic/radiation therapy
L01XD01 - porfimer sodium
L01XD04 - aminolevulinic acid
L01XD05 - temoporfin
L01XD07 - padeliporfin
L01XE - Protein kinase inhibitors
L01XE01 - pivagabine
L01XE02 - gefitinib
L01XE03 - beclometasone
L01XE04 - sunitinib
L01XE05 - sorafenib
L01XE06 - dasatinib
L01XE07 - lapatinib
L01XE08 - nilotinib
L01XE09 - temsirolimus
L01XE10 - everolimus
L01XE11 - pazopanib
L01XE12 - vandetanib
L01XE13 - afatinib
L01XE14 - bosutinib
L01XE15 - vemurafenib
L01XE16 - crizotinib
L01XE17 - axitinib
L01XE18 - ruxolitinib
L01XE21 - regorafenib
L01XE22 - masitinib
L01XE23 - dabrafenib
L01XE24 - ponatinib
L01XE25 - trametinib
L01XE26 - dihydrostreptomycin
L01XE27 - ibrutinib
L01XE28 - ceritinib
L01XE29 - rolapitant
L01XE31 - nintedanib
L01XE33 - palbociclib
L01XE34 - tivozanib
L01XE35 - osimertinib
L01XE36 - alectinib
L01XE38 - cobimetinib
L01XE39 - midostaurin
L01XE41 - binimetinib
L01XE42 - ribociclib
Kisqali (active)
L01XE43 - brigatinib
L01XE44 - lorlatinib
L01XE45 - neratinib
L01XE46 - encorafenib
L01XE47 - dacomitinib
L01XE50 - abemaciclib
L01XE53 - larotrectinib
L01XX - Other antineoplastic agents
L01XX02 - asparaginase
L01XX05 - hydroxycarbamide
L01XX17 - topotecan
L01XX19 - irinotecan
L01XX22 - reboxetine
L01XX23 - mitotane
L01XX24 - pegaspargase
L01XX25 - bexarotene
L01XX27 - desvenlafaxine
L01XX32 - bortezomib
L01XX33 - celecoxib
L01XX35 - anagrelide
L01XX39 - romidepsin
L01XX41 - eribulin
L01XX42 - panobinostat
L01XX43 - vismodegib
L01XX44 - aflibercept
L01XX45 - carfilzomib
L01XX46 - olaparib
L01XX47 - idelalisib
L01XX48 - sonidegib
L01XX50 - ixazomib
L01XX51 - talimogene laherparepvec
L01XX52 - venetoclax
L01XX54 - niraparib
L01XX55 - rucaparib
L01XX56 - etirinotecan pegol
L01XX57 - plitidepsin
L01XX60 - talazoparib
L01XY - Combinations of cytostatics
L01XY01 - cytarabine and daunorubicin
L02 - Endocrine therapy
L02A - Hormones and related agents
L02AE - Gonadotrophin releasing hormone analogues
L02AE03 - goserelin
L02B - Hormone antagonists and related agents
L02BA - Anti-estrogens
L02BA02 - toremifene
L02BA03 - fulvestrant
L02BB - Anti-androgens
L02BB03 - bicalutamide
L02BB04 - enzalutamide
L02BB05 - apalutamide
L02BG - Enzyme inhibitors
L02BG03 - anastrozole
L02BG04 - letrozole
L02BX - Other hormone antagonists and related agents
L02BX02 - degarelix
L02BX03 - abiraterone
L03 - Immunomodulating agents
L03A - Immunostimulating agents
L03AA - Cytokines
L03AA02 - filgrastim
L03AA03 - molgramostim
L03AA13 - pegfilgrastim
L03AA14 - lipegfilgrastim
L03AA15 - balugrastim
L03AB - Interferons
L03AB01 - levacetylmethadol
L03AB05 - interferon gamma
L03AB07 - interferon alfa-2b
L03AB08 - interferon alfa-n1
L03AB09 - interferon beta-1a
L03AB10 - peginterferon alfa-2b
L03AB11 - peginterferon alfa-2a
L03AB13 - peginterferon beta-1a
L03AB15 - ropeginterferon alfa-2b
L03AX - Other immunostimulating agents
L03AX11 - tasonermin
L03AX14 - histamine dihydrochloride
L03AX15 - mifamurtide
L03AX16 - plerixafor
L03AX17 - sipuleucel-T
L03AX19 - dasiprotimut-T
L04 - Immunosuppressants
L04A - Immunosuppressants
L04AA - Selective immunosuppressants
L04AA02 - muromonab-CD3
L04AA06 - mycophenolic acid
L04AA10 - sirolimus
L04AA13 - leflunomide
L04AA21 - efalizumab
L04AA23 - natalizumab
L04AA24 - abatacept
L04AA25 - eculizumab
L04AA26 - ofatumumab
L04AA27 - fingolimod
L04AA28 - eltrombopag
L04AA29 - tofacitinib
L04AA31 - teriflunomide
L04AA32 - apremilast
L04AA33 - vedolizumab
L04AA34 - alemtuzumab
L04AA36 - selective immunosuppressants
L04AA37 - baricitinib
L04AA42 - siponimod
L04AB - Tumor necrosis factor alpha (TNF-Î±) inhibitors
L04AB01 - etanercept
L04AB02 - infliximab
L04AB04 - adalimumab
L04AB05 - certolizumab pegol
L04AB06 - golimumab
L04AC - Interleukin inhibitors
L04AC01 - valdecoxib
L04AC03 - anakinra
L04AC04 - rilonacept
L04AC05 - ustekinumab
L04AC07 - tocilizumab
L04AC08 - canakinumab
L04AC10 - secukinumab
L04AC11 - lopinavir and ritonavir
L04AC12 - brodalumab
L04AC13 - ixekizumab
L04AC14 - sarilumab
L04AC17 - tildrakizumab
L04AD - Calcineurin inhibitors
L04AD02 - tacrolimus
L04AD03 - voclosporin
L04AX - Other immunosuppressive agents
L04AX02 - thalidomide
L04AX03 - methotrexate
L04AX04 - lenalidomide
L04AX05 - pirfenidone
L04AX06 - pomalidomide
L04AX07 - dimethyl fumarate
